120 related articles for article (PubMed ID: 7827939)
1. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist.
Formela LJ; Wood LM; Whittaker M; Kingsnorth AN
Br J Surg; 1994 Dec; 81(12):1783-5. PubMed ID: 7827939
[TBL] [Abstract][Full Text] [Related]
2. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
3. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist.
Galloway SW; Kingsnorth AN
Pancreas; 1996 Aug; 13(2):140-6. PubMed ID: 8829181
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.
Johnson CD
Dig Surg; 1999; 16(2):93-101. PubMed ID: 10207233
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor.
Kingsnorth AN
Scand J Gastroenterol Suppl; 1996; 219():28-31. PubMed ID: 8865468
[TBL] [Abstract][Full Text] [Related]
7. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis.
de Souza LJ; Sampietre SN; Assis RS; Knowles CH; Leite KR; Jancar S; Monteiro Cunha JE; Machado MC
J Gastrointest Surg; 2001; 5(4):364-70. PubMed ID: 11985976
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.
Zhou W; Levine BA; Olson MS
Am J Pathol; 1993 May; 142(5):1504-12. PubMed ID: 8494049
[TBL] [Abstract][Full Text] [Related]
9. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
[TBL] [Abstract][Full Text] [Related]
10. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
11. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
Curtis LD
Adv Exp Med Biol; 1996; 416():361-3. PubMed ID: 9131174
[No Abstract] [Full Text] [Related]
12. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.
Dabrowski A; Gabryelewicz A; Chyczewski L
Int J Pancreatol; 1995 Apr; 17(2):173-80. PubMed ID: 7542692
[TBL] [Abstract][Full Text] [Related]
13. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats.
Liu Q; Djuricin G; Rossi H; Bewsey K; Nathan C; Gattuso P; Weinstein RA; Prinz RA
Am Surg; 1999 Jul; 65(7):611-6; discussion 617. PubMed ID: 10399968
[TBL] [Abstract][Full Text] [Related]
14. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
Wang X; Sun Z; Börjesson A; Haraldsen P; Aldman M; Deng X; Leveau P; Andersson R
Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis affects non-parenchymal liver cells by a mechanism dependent on platelet-activating factor.
Souza LJ; Shio MT; Molan NA; Machado MC; Jancar S
Pancreatology; 2007; 7(1):67-73. PubMed ID: 17449968
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet-activating factor in the pathogenesis of acute pancreatitis.
Liu LR; Xia SH
World J Gastroenterol; 2006 Jan; 12(4):539-45. PubMed ID: 16489665
[TBL] [Abstract][Full Text] [Related]
17. Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.
Leonhardt U; Fayyazzi A; Seidensticker F; Stöckmann F; Söling HD; Creutzfeldt W
Int J Pancreatol; 1992 Oct; 12(2):161-6. PubMed ID: 1460331
[TBL] [Abstract][Full Text] [Related]
18. Experimental acute pancreatitis induced by platelet activating factor in rabbits.
Emanuelli G; Montrucchio G; Gaia E; Dughera L; Corvetti G; Gubetta L
Am J Pathol; 1989 Feb; 134(2):315-26. PubMed ID: 2464939
[TBL] [Abstract][Full Text] [Related]
19. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021.
Xia SH; Hu CX; Zhao ZL; Xia GD; Di Y
World J Gastroenterol; 2007 Jun; 13(21):2992-8. PubMed ID: 17589953
[TBL] [Abstract][Full Text] [Related]
20. Release of platelet-activating factor in acute experimental pancreatitis.
Kald B; Kald A; Ihse I; Tagesson C
Pancreas; 1993 Jul; 8(4):440-2. PubMed ID: 8361963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
